Aspen showing upside to R204 despite Trump pulling funds from SAOk this isn't the best formation.
We have the price above 20MA but still below 200MA.
On the other hand, we have a solid bottom formed and a W Formation along with a Box Formation with it.
So with the pull back and the retest, we could get a bounce up which will send the price to potentially R
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.55 USD
235.34 M USD
2.39 B USD
About ASPEN PHARMACARE HLDGS LTD
Sector
Industry
CEO
Stephen Bradley Saad
Website
Headquarters
Durban
Founded
1850
FIGI
BBG000Q536Z4
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
ASPEN nearly ready for a strong shot down to R151.06!Inv Cup and Handle has been forming on Aspen.
The price is >20 and 200 showing that the momentum is down.
I am eagerly waiting for a strong break below, before I look at getting into a long holding short (sell trade).
My first target will be at R151.06
Our opinion on the current state of ASPEN(APN)Aspen (APN) is a global pharmaceutical company that operates in 150 countries, offering a wide range of specialty and branded products designed to address various acute and chronic medical conditions. The company has 25 manufacturing facilities across 15 sites, with its primary product categories in
Aspen Seeking to Push into Weekly Cycle HighAspen is consolidating in a symmetrical triangle, it has good support in the triangle and the median line of Pitchfork. On the weekly perspective we are in time for a half cycle correction hence I expect the price to resolve upwards.
The stop-loss is R185.41
UPDATE: Target Reached Aspen R206.03 - Next target higherSymmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up.
We had further indicators of confirmation for upside to come.
Price>20
Price>200
Target 1 R206.03
So what now? Well we can expect somewhat a consolidation, an
Our opinion on the current state of APNAspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company, operates globally, distributing its products across 150 countries. The company's diversified product range targets various acute and chronic medical conditions, with a focus on thrombosis, anaesthetics, cytotoxics, and nutrit
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.